Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Senate symbolically votes to repeal device tax. Sequester will take about 5 percent from device user fees. More news in brief.

You may also be interested in...

Freshmen Reps Join Early Effort To Kill Device Tax In New Congress

Rep. Eric Paulsen, R-Minn., made a bid to repeal the medical device tax at the start of the new session in a bill that would be retroactive to the 2013 tax year and has attracted 253 cosponsors, including 26 Democrats.

Device Firm Dollars Go To Senators Favoring Repeal Of Excise Tax

In the upcoming 2014 Senate election, medtech firms spending the most campaign dollars are backing Senators who would vote to repeal the device excise tax, Republican incumbents, and friends to the industry running tight races. Story and detailed data infographic on key races and campaign contributions.

Budget Accord Should Increase FDA Funding, Free Up User Fees

The deal, which sets total FY 2014 discretionary spending at $1.012 trillion, leaves specific appropriations up to congressional committees and frees up user fees from sequestration for two years, both positive developments for FDA’s financial health. Device groups also tout a non-binding provision to repeal the device tax.

Related Content

Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts